Merative

Merative is what became of IBM Watson Health after IBM sold that business in 2022 — now a standalone healthcare data, analytics, and technology company. It carries a portfolio of well-established healthcare products, from the Micromedex clinical reference used by clinicians worldwide to Merge medical imaging and Truven real-world data. With AI and analytics applied to clinical decisions and health data, it serves the serious end of healthcare technology for providers, payers, governments, and life-sciences firms.

What is Merative?

Merative is a healthcare data, analytics, and technology company formed in 2022 when IBM divested its Watson Health business to Francisco Partners, which relaunched it under the Merative name. It provides software and data products across the healthcare and life-sciences sector, with a portfolio that includes Micromedex (a widely used clinical decision support and drug reference resource for clinicians), Merge (medical imaging and enterprise imaging solutions), Truven and other real-world data and analytics assets (used by payers, governments, employers, and life-sciences companies for population health, cost, and outcomes analysis), and Zelta (clinical trial data management), among others. It applies AI and advanced analytics to clinical decision support, imaging workflows, and health data analysis, aimed at improving decisions, efficiency, and outcomes. It serves hospitals and health systems, health plans and payers, government health agencies, employers, and life-sciences organizations. As an enterprise healthcare platform handling sensitive data, it emphasizes compliance and security, and pricing is arranged with sales.

What it does well

• Established portfolio: Micromedex, Merge, Truven, and more.
• Clinical decision support trusted by clinicians worldwide.
• Real-world data: analytics for payers and life sciences.
• AI and analytics applied to serious healthcare problems.

Who it is for

Merative fits healthcare organizations and the wider health ecosystem — hospitals and health systems, health plans and payers, government health agencies, employers, and life-sciences companies — that need established clinical decision support, medical imaging, real-world data, and analytics, now under a standalone healthcare-focused company. Its Micromedex and imaging products are long-trusted. It is not a consumer or general-business tool, it is enterprise-priced via sales, and healthcare AI always requires clinical oversight and validation. For serious healthcare data and analytics, though, Merative is a capable, well-established choice.

Things to keep in mind

• It is an enterprise healthcare platform, not a consumer or general tool.
• Healthcare AI requires clinical oversight and validation.
• Pricing is arranged via sales for enterprise deployment.

Our verdict

Merative is a capable, well-established healthcare data and analytics company — the standalone business that emerged when IBM divested Watson Health in 2022. Its portfolio carries real weight: Micromedex clinical decision support trusted by clinicians worldwide, Merge medical imaging, Truven real-world data for payers and life sciences, and clinical-trial data tools, with AI and analytics applied across clinical decisions, imaging, and health data. It is strictly an enterprise healthcare platform, priced via sales, and healthcare AI needs clinical oversight, but for serious healthcare data and analytics, Merative is a solid choice.

Frequently asked questions

What is Merative?

Merative is a healthcare data, analytics, and technology company formed in 2022 from IBM’s divested Watson Health business, offering clinical decision support, imaging, and real-world data products.

Is Merative the same as IBM Watson Health?

Merative is the standalone company created when IBM sold its Watson Health business to Francisco Partners in 2022; it carries forward that portfolio under a new name.

What products does Merative offer?

Its portfolio includes Micromedex clinical decision support, Merge medical imaging, Truven and other real-world data and analytics, and Zelta clinical trial data management.

Who is Merative for?

It is for hospitals and health systems, payers, government health agencies, employers, and life-sciences companies needing healthcare data, analytics, and decision support.